Chase Investment Counsel Corp Abb Vie Inc. Transaction History

Chase Investment Counsel Corp

$296 Million
Q3 2024

A detailed history of Chase Investment Counsel Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Chase Investment Counsel Corp holds 4,920 shares of ABBV stock, worth $877,678. This represents 0.33% of its overall portfolio holdings.

Number of Shares

4,920

Previous 4,942 0.45%

Holding current value

$877,678

Previous $847,000 14.64%

% of portfolio

0.33%

Previous 0.3%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $3,604 - $4,385	-22 Reduced 0.45%	4,920 $971,000
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $70,739 - $82,607	457 Added 10.19%	4,942 $847,000
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $28,927 - $32,960	181 Added 4.21%	4,485 $816,000
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $8,816 - $10,206	66 Added 1.56%	4,304 $641,000
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $257,069 - $319,906	-1,940 Reduced 31.4%	4,238 $570,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $3.6 Million - $4.15 Million	-24,912 Reduced 80.13%	6,178 $984,000
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $2.24 Million - $2.68 Million	-16,177 Reduced 34.22%	31,090 $5.02 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $59,991 - $68,806	-447 Reduced 0.94%	47,267 $6.34 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $407,355 - $517,881	-2,960 Reduced 5.84%	47,714 $7.31 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $230,569 - $286,071	1,747 Added 3.57%	50,674 $8.21 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $2.83 Million - $3.58 Million	26,347 Added 116.68%	48,927 $6.62 Million
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $29,685 - $33,697	279 Added 1.25%	22,580 $2.44 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $48,592 - $53,494	475 Added 2.18%	22,301 $2.41 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $8,161 - $9,578	95 Added 0.44%	21,826 $1.91 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $1.32 Million - $1.77 Million	18,016 Added 484.95%	21,731 $2.13 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $825,922 - $1.25 Million	-12,805 Reduced 77.51%	3,715 $283,000
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $1.19 Million - $1.49 Million	16,520 New	16,520 $1.46 Million
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $216,686 - $255,029	-2,809 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $7,006 - $8,640	-90 Reduced 3.1%	2,809 $258,000
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $53,523 - $59,501	602 Added 26.21%	2,899 $274,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $6,733 - $7,967	75 Added 3.38%	2,297 $212,000
Q1 2018 May 07, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 Added 4.71%	2,222 $210,000
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $16,837 - $18,463	-188 Reduced 8.14%	2,122 $205,000
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $161,353 - $206,098	2,310	2,310 $205,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Account

Chase Investment Counsel Corp Abb Vie Inc. Transaction History